Stay updated with breaking news from Nuclear Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
The pCPA agreement will support the public listings and reimbursement of XPOVIO. XPOVIO represents the first new drug class for the treatment of early relapsed or refractory multiple myeloma introduced
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
StockNews.com began coverage on shares of Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) in a report published on Thursday. The brokerage issued a hold rating on the stock. KPTI has been the topic of a number of other research reports. Piper Sandler began coverage on Karyopharm Therapeutics in a research report on Thursday, January 19th. They […]
StockNews.com initiated coverage on shares of Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) in a research report released on Thursday morning. The brokerage issued a hold rating on the stock. Other research analysts have also recently issued research reports about the stock. Morgan Stanley decreased their target price on shares of Karyopharm Therapeutics from $7.00 to […]